Literature DB >> 22511000

Gonococcal septic shock associated with eculizumab treatment.

Julie Gleesing, Saurabh Chiwane, Chokechai Rongkavilit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511000     DOI: 10.1097/INF.0b013e3182503849

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  5 in total

1.  Unusual Neisseria species as a cause of infection in patients taking eculizumab.

Authors:  Page E Crew; Lucy McNamara; Peter E Waldron; Lynda McCulley; S Christopher Jones; Susan J Bersoff-Matcha
Journal:  J Infect       Date:  2018-11-06       Impact factor: 6.072

2.  Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series.

Authors:  Page E Crew; Winston E Abara; Lynda McCulley; Peter E Waldron; Robert D Kirkcaldy; Emily J Weston; Kyle T Bernstein; S Christopher Jones; Susan J Bersoff-Matcha
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

Review 3.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

4.  Eculizumab hepatotoxicity in pediatric aHUS.

Authors:  Wesley Hayes; Sibylle Tschumi; Simon C Ling; Janusz Feber; Michael Kirschfink; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2014-11-22       Impact factor: 3.651

Review 5.  Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes.

Authors:  Renaud Prével; Yahsou Delmas; Vivien Guillotin; Didier Gruson; Etienne Rivière
Journal:  J Clin Med       Date:  2022-02-01       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.